News: Keryx Biopharmaceuticals Inc (KERX.PH)

KERX.PH on Philadelphia Stock Exchange

15.91USD
21 Oct 2014
Price Change (% chg)

$0.39 (+2.51%)
Prev Close
$15.52
Open
$15.40
Day's High
$16.05
Day's Low
$15.40
Volume
10,977
Avg. Vol
--
52-wk High
--
52-wk Low
--

Search Stocks
Select another date:

Fri, Sep 5 2014

UPDATE 1-FDA approves Keryx's kidney drug with warnings, shares fall

Sept 5 - Keryx Biopharmaceuticals Inc won U.S. approval for its drug to lower phosphate levels in patients with chronic kidney disease (CKD), but the approval included an unexpected safety warning on the label.

Keryx Biopharma gets U.S. approval for kidney drug

Sept 5 - Keryx Biopharmaceuticals Inc won the U.S. Food and Drug Administration approval for its drug to lower phosphate levels in patients with chronic kidney disease who are already on dialysis.

Keryx drug improves phosphorus, iron in kidney patients: trial

- A pivotal trial of Keryx Biopharmaceuticals Inc's experimental drug Zerenex showed that it improved levels of serum phosphorus and iron in patients on kidney dialysis, according to results published on Thursday.

Keryx drug improves phosphorus, iron in kidney patients -trial

July 24 - A pivotal trial of Keryx Biopharmaceuticals Inc's experimental drug Zerenex showed that it improved levels of serum phosphorus and iron in patients on kidney dialysis, according to results published on Thursday.

DIARY-U.S. MEETINGS/WEEK AHEAD

THOMSON REUTERS, June 23,2014 - Corporate Meetings for US companies for Week ahead. S&P 500 Earnings - Weekly S&P 500 Earnings - Day Ahead Non S&P 500 - Weekly Non S&P 500 - Day Ahead ConferenceCall/Webcast - Weekly ConferenceCall/Webcast - Day S&P 500 Earnings - Monthly Meetings - Day Ahead Economic Indicators Dividends Daily earnings hits & misses Federal Res

Select another date:
Search Stocks